Location History:
- Chungsheongbuk-do, KR (2012)
- Chungcheongbuk-do, KR (2017)
Company Filing History:
Years Active: 2012-2017
Title: The Innovative Contributions of Je-In Youn in Cervical Cancer Research
Introduction: Je-In Youn, an accomplished inventor based in Chungsheongbuk-do, South Korea, has made significant strides in the field of medical research and biotechnology. With a total of two patents to his name, Youn has focused his work on the treatment and prevention of cervical cancer, particularly through the utilization of human papillomavirus (HPV) polypeptides.
Latest Patents: Youn's latest patents revolve around innovative compositions comprising HPV polypeptides and immunoenhancement peptides aimed at addressing cervical cancer. One of his key inventions is a fusion protein that includes a polypeptide of E6 and E7 from the human papillomavirus, paired with a signal peptide to facilitate secretion from cells and an immune enhancing peptide. This invention also details a polynucleotide encoding the fusion protein, along with a vector for delivering the polynucleotide. Additionally, the patent outlines a pharmaceutical composition that utilizes this fusion protein or vector, and presents a method for treating diseases caused by HPV using the developed pharmaceutical solutions.
Career Highlights: Je-In Youn has worked with several prestigious organizations during his career, notably including the Postech Foundation and Genexine Co., Ltd. His contributions to these companies exemplify his commitment to advancing medical science and his dedication to finding effective treatments for complex health issues.
Collaborations: Throughout his career, Youn has collaborated with notable professionals in his field, including Young Chul Sung and Hyun Tak Jin. These partnerships have likely enhanced his research outcomes and contributed to the success of his innovative projects.
Conclusion: Je-In Youn is a pioneering figure in the realm of cervical cancer research, with his patents illustrating a commitment to developing novel therapies. His work not only demonstrates the potential of biotechnology in addressing significant health challenges but also highlights the importance of collaboration and innovation in scientific progress.